Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dyslipidemia

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    April 2016
  1. TOBERT JA, Newman CB
    Management of Dyslipidemia for Cardiovascular Disease Risk Reduction.
    Ann Intern Med. 2016;164:509.
    PubMed     Text format    


  2. DOWNS JR, O'Malley PG
    Management of Dyslipidemia for Cardiovascular Disease Risk Reduction.
    Ann Intern Med. 2016;164:509-10.
    PubMed     Text format    


    January 2016
  3. TAYLOR WC
    Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease.
    Ann Intern Med. 2016;164:135.
    PubMed     Text format    


  4. LLOYD-JONES DM, Goff DC, Stone NJ
    Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease.
    Ann Intern Med. 2016;164:135.
    PubMed     Text format    


    November 2015
  5. SANTOS RD
    ACP Journal Club: ACC/AHA guidelines determining statin eligibility better predicted CVD than ATP-III guidelines.
    Ann Intern Med. 2015;163:JC11.
    PubMed     Text format    


    August 2015
  6. MITTLEMAN MA, Taylor WC, Smetana G, Burns RB, et al
    Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease: Grand Rounds Discussion From the Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2015;163:280-90.
    PubMed     Text format     Abstract available


  7. CORNELL JE, Mulrow CD
    Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.
    Ann Intern Med. 2015;163:242-3.
    PubMed     Text format    


  8. BATTAGGIA A, Donzelli A, Font M
    Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.
    Ann Intern Med. 2015;163:241-2.
    PubMed     Text format    


  9. LIAKOS A, Athanasiadou E, Mainou M, Bekiari E, et al
    Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.
    Ann Intern Med. 2015;163:241.
    PubMed     Text format    


    July 2015
  10. CAINZOS-ACHIRICA M, Martin SS, Cornell JE, Mulrow CD, et al
    PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
    Ann Intern Med. 2015;163:64-5.
    PubMed     Text format    


    June 2015
  11. PATEL SA, Winkel M, Ali MK, Narayan KM, et al
    Cardiovascular Mortality Associated With 5 Leading Risk Factors: National and State Preventable Fractions Estimated From Survey Data.
    Ann Intern Med. 2015 Jun 30. doi: 10.7326/M14-1753.
    PubMed     Text format     Abstract available


  12. DOWNS JR, O'Malley PG
    Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
    Ann Intern Med. 2015 Jun 23. doi: 10.7326/M15-0840.
    PubMed     Text format     Abstract available


    May 2015
  13. LUCATORTO MA, Morgan S
    Effects of nurse-managed protocols.
    Ann Intern Med. 2015;162:669.
    PubMed     Text format    


    April 2015
  14. NAVARESE EP, Kolodziejczak M, Schulze V, Gurbel PA, et al
    Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2015 Apr 28. doi: 10.7326/M14-2957.
    PubMed     Text format     Abstract available


    December 2014
  15. SCHULMAN KA
    Review: in adult outpatients, nurse-managed protocols improve hemoglobin A1c levels and blood pressure.
    Ann Intern Med. 2014;161:JC6.
    PubMed     Text format    


    November 2014
  16. BLOOMFIELD HE
    ACP Journal Club: adding niacin plus laropiprant to statins did not reduce vascular events and increased serious adverse events.
    Ann Intern Med. 2014;161:JC8.
    PubMed     Text format    


  17. TSUJIMOTO T, Yamamoto-Honda R
    Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy.
    Ann Intern Med. 2014;161:678-9.
    PubMed     Text format    


    October 2014
  18. DE JONG HJ, Meyboom RH, Helle MJ, Klungel OH, et al
    Giant cell arteritis and polymyalgia rheumatica after reexposure to a statin: a case report.
    Ann Intern Med. 2014;161:614-5.
    PubMed     Text format    


  19. JOY TR, Zou GY, Mahon JL
    N-of-1 (single-patient) trials for statin-related myalgia.
    Ann Intern Med. 2014;161:531-2.
    PubMed     Text format    


  20. AKINBORO O, Williams L, Pomerantz D
    N-of-1 (single-patient) trials for statin-related myalgia.
    Ann Intern Med. 2014;161:531.
    PubMed     Text format    


    August 2014
  21. LEFEVRE ML
    Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: U.S. Preventive Services Task Force Recommendation Statement.
    Ann Intern Med. 2014 Aug 26. doi: 10.7326/M14-1796.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: